IGM Biosciences Inc (IGMS)
10.35
-0.87
(-7.75%)
USD |
NASDAQ |
Nov 14, 12:47
IGM Biosciences Max Drawdown (5Y): 96.75% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 96.75% |
| September 30, 2024 | 96.75% |
| August 31, 2024 | 96.75% |
| July 31, 2024 | 96.75% |
| June 30, 2024 | 96.75% |
| May 31, 2024 | 96.75% |
| April 30, 2024 | 96.75% |
| March 31, 2024 | 96.75% |
| February 29, 2024 | 96.75% |
| January 31, 2024 | 96.75% |
| December 31, 2023 | 96.75% |
| November 30, 2023 | 96.75% |
| October 31, 2023 | 96.75% |
| September 30, 2023 | 94.51% |
| August 31, 2023 | 94.10% |
| July 31, 2023 | 92.70% |
| June 30, 2023 | 92.70% |
| May 31, 2023 | 91.77% |
| April 30, 2023 | 91.77% |
| March 31, 2023 | 89.05% |
| February 28, 2023 | 89.05% |
| January 31, 2023 | 89.05% |
| December 31, 2022 | 89.05% |
| November 30, 2022 | 89.05% |
| October 31, 2022 | 89.05% |
| Date | Value |
|---|---|
| September 30, 2022 | 89.05% |
| August 31, 2022 | 89.05% |
| July 31, 2022 | 89.05% |
| June 30, 2022 | 89.05% |
| May 31, 2022 | 89.05% |
| April 30, 2022 | 88.93% |
| March 31, 2022 | 88.93% |
| February 28, 2022 | 87.38% |
| January 31, 2022 | 86.10% |
| December 31, 2021 | 77.24% |
| November 30, 2021 | 61.30% |
| October 31, 2021 | 61.30% |
| September 30, 2021 | 57.27% |
| August 31, 2021 | 57.27% |
| July 31, 2021 | 57.27% |
| June 30, 2021 | 57.27% |
| May 31, 2021 | 57.27% |
| April 30, 2021 | 57.27% |
| March 31, 2021 | 57.27% |
| February 28, 2021 | 57.27% |
| January 31, 2021 | 57.27% |
| December 31, 2020 | 57.27% |
| November 30, 2020 | 57.27% |
| October 31, 2020 | 57.27% |
| September 30, 2020 | 57.27% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
29.01%
Minimum
Nov 2019
96.75%
Maximum
Oct 2023
76.05%
Average
88.99%
Median
Max Drawdown (5Y) Benchmarks
| Moderna Inc | 89.10% |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |